xi's moments
Home | Americas

8k8 log in

诺和诺德司美格鲁肽在中国获批用于长期体重管理,可实现17%的体重平均降幅 | 8k8 log in | Updated: 2024-08-14 00:23:04

Global Edition
BACK TO THE TOP
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349